BGS Foundation - about bgs foundation




List of Drugs Prohibited for Manufacture and Sale through Gazette Notifications under Section 26a of Drugs & Cosmetics act 1940 by the Ministry of Health and Family Welfare

Drugs Prohibited from the date of Notification


Fixed dose combinations of vitamins with anti–inflammatory agents and tranquilizers.

Fixed dose combinations of Atropine in Analgesics and Antipyretics.

Fixed dose combinations of Strychnine and Caffeine in tonics.

Fixed dose combinations of Yohimbine and Strychnine with Testosterone and Vitamins.

Fixed dose combinations of Iron with Strychnine, Arsenic and Yohimbine.

Fixed dose combinations of Sodium Bromide/chloral hydrate with other drugs.


Fixed dose combinations of antihistaminic with anti-diarrhoeals.

Fixed dose combinations of Penicillin with Sulphonamides.

Fixed dose combinations of Vitamins with Analgesics.

Fixed dose combinations of any other Tetracycline with Vitamin C.

Fixed dose combinations of Hydroxyquinoline group of drugs with any other drug except for preparations meant for external use.

Fixed dose combinations of Corticosteroids with any other drug for internal use.

Fixed dose combinations of Chloramphenicol with any other drug for internal use.

Fixed dose combinations of crude Ergot preparations except those containing Ergotamine, Caffeine, analgesics, antihistamines for the treatment of migraine, headaches.

Fixed dose combinations of Vitamins with Anti TB drugs except combination of Isoniazid with Pyridoxine Hydrochloride (Vitamin B6).

Penicillin skin/eye Ointment.

Tetracycline Liquid Oral preparations.



Methapyrilene, its salts.


Oxytetracycline Liquid Oral preparations.

Demeclocycline Liquid Oral preparations.

Combination of anabolic Steroids with other drugs.

Fixed dose combination of Oestrogen and Progestin (other than oral contraceptive) containing per tablet estrogen content of more than 50 mcg (equivalent to Ethinyl Estradiol) and progestin content of more than 3 mg (equivalent to Norethisterone Acetate) and all fixed dose combination injectable preparations containing synthetic Oestrogen and Progesterone. (Subs. By Noti. No. 743 (E) dt 10-08-1989)

Fixed dose combination of Sedatives/ hypnotics/anxiolytics with analgesics-antipyretics.

Fixed dose combination of Rifanpicin, isoniazid and Pyrazinamide, except those which provide daily adult dose given below:

Drugs                    Minimum    Maximum
Rifampicin             450 mg    600 mg
Isoniazid                300 mg    400 mg
Pyrazinamide         1000mg    1500 mg

Fixed dose combination of Histamine H-2 receptor antagonists with antacids except for those combinations approved by Drugs Controller, India.

The patent and proprietary medicines of fixed dose combinations of essential oils with alcohol having percentage higher than 20% proof except preparations given in the Indian Pharmacopoeia.

All Pharmaceutical preparations containing Chloroform exceeding 0.5% w/w or v/v whichever is appropriate.

Fixed dose combination of Ethambutol with INH other than the following: INH Ethambutol 200 mg. 600 mg. 300 mg. 800 mg.

Fixed dose combination containing more than one antihistamine.

Fixed dose combination of any anthelmintic with cathartic/purgative except for piperazine/Santonim.

Fixed dose combination of Salbutamol or any other bronchodilator with centrally acting anti-tussive and/or antihistamine.

Fixed dose combination of laxatives and/or anti-spasmodic drugs in enzyme preparations.

Fixed dose combination of Metoclopramide with systemically absorbed drugs except fixed dose combination of metoclopramide with aspirin/paracetamol

Fixed dose combination of centrally acting, antitussive with antihistamine, having high atropine like activity in expectorants.

Preparations claiming to combat cough associated with asthma containing centrally acting antitussive and/ or an antihistamine.

Liquid oral tonic preparations containing glycerophosphates and/or other phosphates and / or central nervous system stimulant and such preparations containing alcohol more than 20% proof.

Fixed dose combination containing Pectin and/or Kaolin with any drug which is systemically absorbed from GI tract except for combinations of Pectin and/or Kaolin with drugs not systemically absorbed.

Chloral Hydrate as a drug.

Dovers Powder I.P.

Dover’s Powder Tablets I.P.

Antidiarrhoeal formulations containing Kaolin or Pectin or Attapulgite or Activated Charcoal.

Antidiarrhoeal formulations containing Phthalyl Sulphathiazole or Sulphaguanidine or Succinyl Sulphathiazole.

Antidiarrhoeal formulations containing Neomycin or Streptomycin or Dihydrostreptomycin including their respective salts or esters.

Liquid Oral antidiarrhoeals or any other dosage form for pediatric use containing Diphenoxylate Lorloperamide or Atropine or Belladona including their salts or esters or metabolites Hyoscyamine or their extracts or their alkaloids.

Liquid Oral antidiarrhoeals or any other dosage form for pediatric use containing halogenated hydroxyquinolines.

Fixed dose combination of antidiarrhoeals with electrolytes.

Patent and Proprietary Oral Rehydration Salts other than those conforming to the

Fixed dose combination of Oxyphenbutazone or Phenylbutazone with any other drug.

Fixed dose combination of Analgin with any other drug.

Fixed dose combination of dextropropoxyphene with any other drug other than anti-spasmodics and/or non-steriodal anti-inflammatory drugs (NSAIDS).

Fixed dose combination of a drug, standards of which are prescribed in the Second Schedule to the said Act with an Ayurvedic, Siddha or Unani drug.

Mepacrine Hydrochloride (Quinacrine and its salts) in any dosage form for use for female sterilization or contraception.

Fenfluramine and Dexfenfluramine.

Fixed dose combination of Diazepam and Diphenhydramine Hydrochloride.



Nimesulide formulations for human use in children below 12 years of age.

Cisapride and its formulations for human use.

Phenylpropanolamine and its formulation for human use.

Human Placental Extract and its formulations for human use.

Sibutramine and its formulations for human use, and

R-Sibutramine and its formulations for human use.

Gatifloxacin formulation for systemic use in human by any route including oral and injectable

Tegaserod and its formulation for human use.




Our Aim is to focus on major crises prevailing in society. But we would approach in step-by-step manner. Major part of our activities are yet to begin however the work has already initiated to engage in the cause of it.

We are ready to assist you at every stage of your crises. Feel free to approach us in your journey to create a better life - a better world. Write to us:


To donate click on the Donate Now button and select the cause for which you want to donate.

To take action click on the Take Action button and rest be assured that your identity will be kept confidential.



Regd. no.: 270633

Donate Now